By Elise Viebeck - 02/26/13 08:42 PM EST
The medical device industry is "one of the few that creates a trade surplus," said David Dvorak, AdvaMed's chairman of the board.
Dvorak argued that the tax's logic — that it would be counter-balanced by a wave of business for device manufacturers as new patients enter the healthcare system — has "fallen apart."
"We are sending $97 million to the [Internal Revenue Service] every two weeks," he said. "That is money that could be going toward research and development."
The remarks took place at a press luncheon in Washington.